Aytu BioPharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | 384.3% | 384.3% | -599.0% |
| FY2012 | 85.6% | 85.6% | -471.9% |
| FY2013 | 51.7% | 51.7% | -592.8% |
| FY2014 | -103.9% | -103.9% | -46.4% |
| FY2015 | -49.5% | -49.5% | -42.5% |
| FY2016 | -279.4% | -279.4% | -115.8% |
| FY2017 | -562.7% | -562.7% | -150.1% |
| FY2018 | -75.9% | -75.9% | -48.4% |
| FY2019 | -382.8% | -382.8% | -78.1% |
| FY2020 | -14.3% | -14.3% | -8.9% |
| FY2021 | -42.4% | -42.3% | -21.9% |
| FY2022 | -245.5% | -183.4% | -79.0% |
| FY2023 | -43.3% | -31.5% | -12.5% |
| FY2024 | -57.2% | -41.1% | -13.4% |
| FY2025 | -71.5% | -45.4% | -10.9% |
| FY2026 | -40.4% | -32.1% | -13.6% |